BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manganotti P, Bellavita G, Tommasini V, D Acunto L, Fabris M, Cecotti L, Furlanis G, Sartori A, Bonzi L, Buoite Stella A, Pesavento V. Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients. J Med Virol 2021;93:5432-7. [PMID: 33951196 DOI: 10.1002/jmv.27061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Diaz P, Leveque M, Hautecloque G, Sellal F, Augereau O, Lita L, Biegle E, Belilita L, Boutera C, Rerat P, Gonzalez AA, Martinot M, Gerber V. The challenge of diagnosing Guillain–Barre syndrome in patients with COVID-19 in the intensive care unit. Journal of Neuroimmunology 2022. [DOI: 10.1016/j.jneuroim.2022.577842] [Reference Citation Analysis]
2 Finsterer J, Almas T. Guillain-Barré syndrome is immunogenic in SARS-CoV-2 infected. J Med Virol 2022;94:22-3. [PMID: 34468997 DOI: 10.1002/jmv.27314] [Reference Citation Analysis]
3 Buoite Stella A, Furlanis G, Frezza NA, Valentinotti R, Ajcevic M, Manganotti P. Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study. J Neurol 2021. [PMID: 34386903 DOI: 10.1007/s00415-021-10735-y] [Reference Citation Analysis]
4 Balbi P, Saltalamacchia A, Lullo F, Fuschillo S, Ambrosino P, Moretta P, Lanzillo B, Maniscalco M. Peripheral Neuropathy in Patients Recovering from Severe COVID-19: A Case Series. Medicina 2022;58:523. [DOI: 10.3390/medicina58040523] [Reference Citation Analysis]